Century Therapeutics, Inc. (IPSC): Free Cash Flow
-$104.72M
Year ended 2025-12-31
-$88.09M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$104.72M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$110.29M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$102.08M | n/m | 2025-03-19, From 2023-01-01 |
| 2022-12-31 | -$16.55M | n/m | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | -$133.97M | n/m | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | -$51.09M | n/a | 2022-03-17, From 2020-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | 2025-12-31 | -$104.72M | n/m |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | -$308.78M | n/m |
| Agenus Inc (AGEN) | 2025-12-31 | -$77.20M | n/m |
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | -$50.94M | n/m |
| Monte Rosa Therapeutics, Inc. (GLUE) | 2025-12-31 | -$27.50M | n/m |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | -$360.05M | n/m |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | -$109.62M | n/m |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | -$50.19M | n/m |
| Autolus Therapeutics plc (AUTL) | 2025-12-31 | -$302.61M | n/m |
Compare IPSC, IBRX, AGEN, ATRA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗